Munoz, Miguel. 2026. “Aprepitant, When Used With Chemotherapy, Reduces the Risk of Recurrence, Metastasis, And Mortality in Patients With Breast Cancer: Aprepitant in Breast Cancer Outcomes”. Pakistan Journal of Health Sciences 7 (8). Pakistan:01-02. https://doi.org/10.54393/pjhs.v7i8.4537.